Evidence review

Peptide Purity, COAs, and Source Verification

#peptide#topic
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `peptide-purity-coa`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/peptide-purity-coa

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/peptide-purity-coa/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/peptide-purity-coa/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/peptide-purity-coa/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/peptide-purity-coa/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*
What is known
  • 2023 paper describing a chiral HPLC-ESI-MS/MS method for determining amino acid chiral purity in synthetic peptides, with GMP validation feasibility and application to model peptides.
  • 2023 paper proposing GC-ID-IR spectroscopy as a primary method for peptide purity analysis.
  • Discusses risk assessment for peptide impurities in drug substances, relevant to purity verification and COA standards.

What Is a COA

A Certificate of Analysis (COA) is a laboratory document summarizing analytical testing on a specific batch of a research compound, including compound name, batch/lot number, analytical methods, purity results, testing date, and laboratory identification. [c1]

Typical COA Contents for Peptides

Non-GMP COAs commonly list amino acid sequence, modifications, purity (often by RP-HPLC), mass spectral data (MS), and appearance. GMP COAs are more comprehensive, including additional specifications. [c2]

Third-Party Testing and Verification Methods

Independent labs use HPLC for purity and Mass Spectrometry (MS) for identity confirmation. Accredited labs (e.g., ISO/IEC 17025) provide validated testing for research peptides. [c3][c4]

American-Made and Manufacturing Standards

Vendors may claim U.S. sourcing or third-party testing, but buyers should verify lot-specific COAs match the product and check for endotoxin or sterility data beyond basic purity. [c5]

Differentiating Sources and Grey Market Risks

Purity percentages (e.g., ≥99%) confirm identity but do not guarantee sterility or absence of endotoxins; grey-market products labeled Research Use Only may lack these controls. Independent testing platforms report on vendor consistency across batches. [c6]

How Buyers Can Verify

Cross-check lot numbers on COA against vial; confirm testing lab independence; request additional assays like endotoxin if relevant for research. No human clinical data supports general claims on peptide sourcing outcomes.

Evidence · 80 sources · swipe →chain 15a31ff24a85 · verify chain · provenance
1 / 80

Key evidence

78 claims · tier-ranked · API
mechanistic
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
human
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
mechanistic
While the disclaimer states that the ledger is not medical advice, it does not explicitly mention the importance of consulting with healthcare professionals who are knowledgeable about peptides, which could be a potential oversight.
system
Peptide Purity, COAs, and Source Verification is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
mechanistic
2023 paper describing a chiral HPLC-ESI-MS/MS method for determining amino acid chiral purity in synthetic peptides, with GMP validation feasibility and application to model peptides.
sources: s19
mechanistic
2023 paper proposing GC-ID-IR spectroscopy as a primary method for peptide purity analysis.
sources: s20
mechanistic
Discusses risk assessment for peptide impurities in drug substances, relevant to purity verification and COA standards.
sources: s21
mechanistic
Emphasizes accurate impurity quantification methods for peptide purity assessment using RRF in HPLC.
sources: s22
anecdotal
Vendor promotes batch-specific QR-linked COAs with multiple tests; users inquire if functional (anecdotal transparency discussion).
sources: s58
anecdotal
Vendor post highlighting ongoing third-party testing of peptide batches and COA delays for source verification.
sources: s70
66 more ranked claims
anecdotal0.30
Vendor post claiming comprehensive batch-specific COA testing including multiple parameters.
grok-4.3
Materialized from orphan source s80 by ledger repair
sources: s80
human0.22low confidence
2024 review on enantiomeric purity assessment for synthetic therapeutic peptides, critical for quality evaluation.
grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
mechanistic0.22low confidence
Regulatory perspective on analytical challenges for peptide impurities and quality assessment.
grok-4.3
Materialized from orphan source s23 by ledger repair
sources: s23
mechanistic0.22low confidence
Covers methods for quantifying coeluting impurities in synthetic peptides for purity verification.
grok-4.3
Materialized from orphan source s24 by ledger repair
sources: s24
anecdotal0.22low confidence
User reports negative experience with Jano testing lab, calling results a joke and alleging block after criticism; contrasts with trusted third-party tests.
grok/grok-4.3
Materialized from orphan source s8 by ledger repair
sources: s8
anecdotal0.22low confidence
Users discuss limited trust in vendor-posted COAs vs independent verification; note potential for recycled docs and batch variability.
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
anecdotal0.22low confidence
User reports bad outcome with AC Peptides vendor, alleging initial real product followed by fakes, based on lab analysis of COA.
grok/grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
anecdotal0.22low confidence
Positive user experience: multiple independent tests by Jano matched distributor COAs over time, leading to long-term trust in one supplier.
grok/grok-4.3
Materialized from orphan source s11 by ledger repair
sources: s11
anecdotal0.22low confidence
Users highlight risks of reused or photoshopped COAs with no chain of custody; overall skepticism on reliability without personal testing.
grok/grok-4.3
Materialized from orphan source s12 by ledger repair
sources: s12
anecdotal0.22low confidence
Explains how to interpret peptide COAs including purity percentages (aim for 98%+), HPLC methods, and red flags like blurry images or uniform perfect purity claims.
grok/grok-4.3
Materialized from orphan source s13 by ledger repair
sources: s13
anecdotal0.22low confidence
Discusses limitations of vendor COAs for peptides and recommends community group testing for verification.
grok/grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
anecdotal0.22low confidence
Provides guide with images on verifying authenticity of COAs for research peptides like tirzepatide.
grok/grok-4.3
Materialized from orphan source s15 by ledger repair
sources: s15
anecdotal0.22low confidence
Anecdotal evidence suggests that some users have reported inconsistent results when comparing COAs from different testing labs, indicating a potential gap in standardization and reliability of testing methods.
kimi/moonshot-v1-8k
This claim identifies a specific anecdotal claim about the inconsistency of COA results from different labs, which is relevant to the topic of peptide purity and COA verification.
sources: s8
anecdotal0.22low confidence
User explains limitations of vendor-provided COAs, noting they don't verify the specific vial received; discusses risks of buying from individuals vs established vendors. BAD outcome implied by lack of accountability.
grok-4.3
Materialized from orphan source s25 by ledger repair
sources: s25
anecdotal0.22low confidence
User reports discovering identical COAs used by multiple vendors at different prices, questioning if it's a red flag for reused/fake documentation. BAD experience with verification process.
grok-4.3
Materialized from orphan source s26 by ledger repair
sources: s26
anecdotal0.22low confidence
User expresses skepticism about COA purity claims not guaranteeing dosage/quantity in vial; BAD outcome potential from under-dosed products despite good purity test.
grok-4.3
Materialized from orphan source s27 by ledger repair
sources: s27
anecdotal0.22low confidence
Users discuss how lot numbers can be faked or reused, leading to potential mismatch with tested batch. BAD outcomes from fabricated documentation.
grok-4.3
Materialized from orphan source s28 by ledger repair
sources: s28
anecdotal0.22low confidence
Community comparison highlights issues like outdated COAs or unnamed labs across vendors; some positive mentions of public batch-specific testing but overall caution on transparency.
grok-4.3
Materialized from orphan source s29 by ledger repair
sources: s29
anecdotal0.22low confidence
User reports positive experience with a vendor's posted COAs and personal results.
grok-4.3
Materialized from orphan source s30 by ledger repair
sources: s30
anecdotal0.22low confidence
User describes sending grey market peptides for endotoxin testing before use.
grok-4.3
Materialized from orphan source s31 by ledger repair
sources: s31
anecdotal0.22low confidence
User shares bad experience with a vendor lacking proper batch info and blurry COA, avoided use.
grok-4.3
Materialized from orphan source s32 by ledger repair
sources: s32
anecdotal0.22low confidence
User warns COAs are marketing, recommends community blind/group testing for verification.
grok-4.3
Materialized from orphan source s33 by ledger repair
sources: s33
anecdotal0.22low confidence
User reports decent experiences buying small from resellers before scaling to bulk China sources.
grok-4.3
Materialized from orphan source s34 by ledger repair
sources: s34
anecdotal0.22low confidence
Commenter reports good outcomes buying directly from multiple Chinese peptide labs.
grok-4.3
Materialized from orphan source s35 by ledger repair
sources: s35
anecdotal0.22low confidence
User shares experience from friends at a manufacturer where HPLC area percentage was used as purity without checking for non-UV active impurities; discusses limitations of single-method testing and need for quantitative NMR in pharma.
grok-4.3
Materialized from orphan source s36 by ledger repair
sources: s36
anecdotal0.22low confidence
User describes bad outcome where claimed high purity failed MS verification; mentions using third-party LC-MS/MS for confirmation when in-house checks fail.
grok-4.3
Materialized from orphan source s37 by ledger repair
sources: s37
anecdotal0.22low confidence
User reports bad experience verifying COA for AusBio Labs supplier; lab confirmation shows no services provided, indicating fake COA.
grok-4.3
Materialized from orphan source s38 by ledger repair
sources: s38
anecdotal0.22low confidence
User reports positive personal outcome (pain relief from BPC-157) despite unverifiable COA and purity concerns; notes friends' long-term use without issues but prefers verified sources.
grok-4.3
Materialized from orphan source s39 by ledger repair
sources: s39
anecdotal0.22low confidence
User describes bad experiences with forged COAs from multiple Telegram vendors; recommends independent testing to avoid being cheated.
grok-4.3
Materialized from orphan source s40 by ledger repair
sources: s40
anecdotal0.22low confidence
Discussion on whether COAs matter for peptide quality and pricing in PH market; notes cost of testing and group vs individual COAs.
grok-4.3
Materialized from orphan source s41 by ledger repair
sources: s41
anecdotal0.22low confidence
Thread on identifying fake COAs for peptides, emphasizing checking vial caps and authenticity.
grok-4.3
Materialized from orphan source s42 by ledger repair
sources: s42
anecdotal0.22low confidence
Proposal for local independent lab in Manila for peptide testing including HPLC, LC-MS, endotoxin; discusses verifiable COAs.
grok-4.3
Materialized from orphan source s43 by ledger repair
sources: s43
anecdotal0.22low confidence
Users discuss switching suppliers based on COA quality, experiences with weight loss plateaus, and need for more than just purity tests (anecdotal).
grok-4.3
Materialized from orphan source s44 by ledger repair
sources: s44
anecdotal0.22low confidence
Questioning if COA alone suffices, suggesting additional tests like heavy metals and contamination for peptides.
grok-4.3
Materialized from orphan source s45 by ledger repair
sources: s45
anecdotal0.22low confidence
Thread sharing COA guidance and verification tips for various peptides.
grok-4.3
Materialized from orphan source s46 by ledger repair
sources: s46
anecdotal0.22low confidence
Discussion on verifying real COAs for peptides, focusing on purity and authenticity checks.
grok-4.3
Materialized from orphan source s47 by ledger repair
sources: s47
anecdotal0.22low confidence
Users discuss red flags and key elements beyond just purity % on peptide COAs.
grok-4.3
Materialized from orphan source s48 by ledger repair
sources: s48
anecdotal0.22low confidence
Advice on vendor checks including batch-specific COA verification and lab reputation.
grok-4.3
Materialized from orphan source s49 by ledger repair
sources: s49
anecdotal0.22low confidence
Step-by-step guide to reading COAs, warning against relying solely on purity numbers (anecdotal discussion).
grok-4.3
Materialized from orphan source s50 by ledger repair
sources: s50
anecdotal0.22low confidence
Technical discussion on HPLC for peptide purity measurement in research context.
grok-4.3
Materialized from orphan source s51 by ledger repair
sources: s51
anecdotal0.22low confidence
X post highlighting prevalence of fake COAs in peptide sourcing.
grok-4.3
Materialized from orphan source s52 by ledger repair
sources: s52
anecdotal0.22low confidence
Post warning about fake COAs from certain peptide sellers on marketplaces.
grok-4.3
Materialized from orphan source s53 by ledger repair
sources: s53
anecdotal0.22low confidence
Discussion on verifying third-party peptide testing labs and COAs in 2026, emphasizing community skepticism on vendor claims.
grok-4.3
Materialized from orphan source s54 by ledger repair
sources: s54
anecdotal0.22low confidence
Users discuss personal testing equipment for peptides beyond vendor COAs; anecdotal preference for third-party verification.
grok-4.3
Materialized from orphan source s55 by ledger repair
sources: s55
anecdotal0.22low confidence
Guide on spotting legitimate COAs for peptides like tirzepatide; warnings about fake documents and health risks (anecdotal context).
grok-4.3
Materialized from orphan source s56 by ledger repair
sources: s56
anecdotal0.22low confidence
Thread on matching tirzepatide batches to COAs; emphasis on verification to avoid counterfeits.
grok-4.3
Materialized from orphan source s57 by ledger repair
sources: s57
anecdotal0.22low confidence
Promotion of pre-published lot-specific COAs with guarantees; focuses on purity verification methods.
grok-4.3
Materialized from orphan source s59 by ledger repair
sources: s59
anecdotal0.22low confidence
User shares independent test results showing slight overfill but 98.1% purity (below typical 99%+ threshold) and notes degradation risk; anecdotal dosing/quality discussion.
grok-4.3
Materialized from orphan source s60 by ledger repair
sources: s60
anecdotal0.22low confidence
Post outlines red flags for fake/shared COAs, emphasizes batch-specific third-party testing; includes advice on verification and warnings about in-house or generic docs.
grok-4.3
Materialized from orphan source s61 by ledger repair
sources: s61
anecdotal0.22low confidence
Thread discusses vendor reliability, fake COAs/purity issues, user warnings about specific bad vendors and need for endotoxin/purity tests; anecdotal experiences shared.
grok-4.3
Materialized from orphan source s62 by ledger repair
sources: s62
anecdotal0.22low confidence
Guide on interpreting COA purity percentages, what HPLC means, and pitfalls; educational post on source verification.
grok-4.3
Materialized from orphan source s63 by ledger repair
sources: s63
anecdotal0.22low confidence
User seeks advice on spotting falsified COAs, lot matching, lab verification; community discussion on peptide source trust issues.
grok-4.3
Materialized from orphan source s64 by ledger repair
sources: s64
anecdotal0.22low confidence
Vendor post highlights user distrust from past bad purity/fake COAs and their QR code solution for real-time verification; promotional but addresses common complaints.
grok-4.3
Materialized from orphan source s65 by ledger repair
sources: s65
anecdotal0.22low confidence
User describes using third-party testing service to verify vendor peptides, shares results showing discrepancies in Retatrutide; anecdotal bad outcome and advocacy for independent verification.
grok-4.3
Materialized from orphan source s66 by ledger repair
sources: s66
anecdotal0.22low confidence
Explains what purity percentages mean on COAs, why identity (MS) and contaminants (endotoxins, heavy metals) matter more than 98% vs 99%, with red flags like identical 99.9% claims across products. Anecdotal: users discuss testing in EU via Janoshik.
grok-4.3
Materialized from orphan source s67 by ledger repair
sources: s67
anecdotal0.22low confidence
Thread about vendors refusing to share COAs publicly, raising source verification concerns.
grok-4.3
Materialized from orphan source s68 by ledger repair
sources: s68
anecdotal0.22low confidence
Discusses independent lab testing of vendor peptides, noting gaps in endotoxin/heavy metals testing on many COAs.
grok-4.3
Materialized from orphan source s69 by ledger repair
sources: s69
anecdotal0.22low confidence
User shares anecdote of bad peptide batch causing research setback; discusses trusting suppliers, third-party testing costs, and using multiple vendors/controls for verification.
grok-4.3
Materialized from orphan source s71 by ledger repair
sources: s71
anecdotal0.22low confidence
Thread on testing Chinese-sourced peptides; users discuss labs (Freedom Diagnostics, Janoshik), >99% purity results (anecdotal), China as common source, red flags like payment methods, and testing for purity/endotoxins/sterility.
grok-4.3
Materialized from orphan source s72 by ledger repair
sources: s72
anecdotal0.22low confidence
User describes new platform CertiPep for public peptide purity/identity verification using MS, LCMS, NMR to supplement vendor COAs; seeks feedback on trust and features.
grok-4.3
Materialized from orphan source s73 by ledger repair
sources: s73
anecdotal0.22low confidence
Discussion on real-world impact of peptide purity percentages on experiments; questions vendor claims and need for better verification.
grok-4.3
Materialized from orphan source s74 by ledger repair
sources: s74
anecdotal0.22low confidence
Australian users discuss difficulties verifying peptide COAs/purity due to local constraints; mentions of independent testing needs.
grok-4.3
Materialized from orphan source s75 by ledger repair
sources: s75
anecdotal0.22low confidence
Discussion on whether a provided vendor COA is trustworthy; consensus leans toward skepticism of vendor COAs and preference for third-party verification like Janoshik. Anecdotal experiences with fake or misleading COAs shared.
grok-4.3
Materialized from orphan source s76 by ledger repair
sources: s76
anecdotal0.22low confidence
User with professional GC analysis experience notes that vendor COAs do not guarantee accuracy or lack of contamination.
grok-4.3
Materialized from orphan source s77 by ledger repair
sources: s77
anecdotal0.22low confidence
User shares independent Canadian lab test results showing high purity (99.33% for Retatrutide, 100% for MOTS-c) and low heavy metals; commenters discuss implications for source verification.
grok-4.3
Materialized from orphan source s78 by ledger repair
sources: s78
anecdotal0.22low confidence
Comment highlighting difficulty in interpreting lab reports without expertise; detailed breakdown provided by another user.
grok-4.3
Materialized from orphan source s79 by ledger repair
sources: s79
Low-confidence / auto-generated 2
speculative0.12
Commercial vendors and clinics market this compound (9 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 12 duplicate marketing claims
sources: s1, s2, s3, s4, s5, s6, s7, s16, s17
speculative0.12
The ledger lacks information on the potential risks and side effects associated with peptides, which is a significant gap as it pertains to the safety and efficacy of these compounds.
kimi/moonshot-v1-8k
This claim addresses a gap in the ledger regarding the safety and efficacy of peptides, which is crucial for users to make informed decisions.
sources: s1
Model swipes · 23 from 5 models · swipe →verify
1 / 23
grok/grok-4.3writer
redraft2026-06-29 09:32
Peptide Purity, COAs, and Source Verification · 6 claims · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "peptide-purity-coas-source-verification",
  "title": "Peptide Purity, COAs, and Source Verification",
  "body": "## What Is a COA\nA Certificate of Analysis (COA) is a laboratory document summarizing analytical testing on a specific batch of a research compound, including compound name, batch/lot number, analytical methods, purity results, testing date, and laboratory identification. [c1]\n\n## Typical COA Contents for Peptides\nNon-GMP COAs commonly list amino acid sequence, modifications, purity (often by RP-HPLC), mass spectral data (MS), and appearance. GMP COAs are more comprehensive, including additional specifications. [c2]\n\n## Third-Party Testing and Verification Methods\nIndependent labs use HPLC for purity and Mass Spectrometry (MS) for identity confirmation. Accredited labs (e.g., ISO/IEC 17025) provide validated testing for research peptides. [c3][c4]\n\n## American-Made and Manufacturing Standards\nVendors may claim U.S. sourcing or third-party testing, but buyers should verify lot-specific COAs match the product and check for endotoxin or sterility data beyond basic purity. [c5]\n\n## Differentiating Sources and Grey Market Risks\nPurity percentages (e.g., ≥99%) confirm identity but do not guarantee sterility or absence of endotoxins; grey-market products labeled Research Use Only may lack these controls. Independent testing platforms report on vend
e842164b6a49b255
grok-4.3source_hunt
sources2026-06-29 12:09
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
5 source(s) added
340f85c822506ae8
grok-4.3source_hunt
sources2026-06-29 12:09
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
5 source(s) added
48c68123674e9404
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
{"materialized":0,"before":[],"after":[]}
1f75b0c22e03859a
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
{"materialized":0,"before":[],"after":[]}
7f01117c45131dbb
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
{"materialized":0,"before":[],"after":[]}
7185bcc18f662c85
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
{"materialized":0,"before":[],"after":[]}
40f8358eb61f0e06
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
{"materialized":0,"before":[],"after":[]}
034f2460e300da16
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 13:52
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
I added claims to address explicit gaps in the ledger and to identify who claims what from anecdotes where missing, as instructed. I am not Grok because I am adding new claims based on the existing topology and instructions, rather than providing a final assessment.
7c68e5abb5d876af
grok-4.3source_hunt
sources2026-06-29 15:03
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
4 source(s) added
7b17ef375d8a5a94
grok-4.3source_hunt
sources2026-06-29 15:03
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
4 source(s) added
46554a920c8e9ce3
grok-4.3source_hunt
sources2026-06-29 16:53
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
5 source(s) added
4b308d46d1a28a9c
grok-4.3source_hunt
sources2026-06-29 16:54
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
5 source(s) added
b7bbe2602e6e6855
grok-4.3source_hunt
sources2026-06-29 16:54
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
5 source(s) added
71b4db6a702a3a66
grok-4.3source_hunt
sources2026-06-29 18:57
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
7 source(s) added
b1ae4cdf78ebff7a
grok-4.3source_hunt
sources2026-06-29 18:57
7 source(s) added · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
7 source(s) added
ece06a48aa9246df
grok-4.3source_hunt
sources2026-06-29 18:58
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
6 source(s) added
e8551747998d97c6
grok-4.3source_hunt
sources2026-06-29 18:59
7 source(s) added · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
7 source(s) added
4965f3416e67d4f5
grok-4.3source_hunt
sources2026-06-29 19:00
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
5 source(s) added
e6e09b95fcb59c5c
grok-4.3source_hunt
sources2026-06-29 19:00
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
5 source(s) added
a5a16fef94b78513
grok-4.3source_hunt
sources2026-06-29 19:01
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa
it output
5 source(s) added
835d3da052c444a8
fill-slotsclaim_post
claim2026-06-29 21:27
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa c89
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
18826cb85427362d
fill-slotsclaim_post
claim2026-06-29 21:27
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: peptide-purity-coa c89
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
01bc1eff57fa4526

Related research

peptide-purity-coa · condition map

Open evidence map →
Benzo Withdrawalshared topicwhat-are-peptides-benzo-withdrawalPeptides and Benzodiazepines: What the Evidence Showsshared topicwhat-are-peptides-benzodiazepinesBrain Fogshared topicwhat-are-peptides-brain-fogCarpal Tunnelshared topicwhat-are-peptides-carpal-tunnel
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. N…"?
ask peptide-purity-coa claim c89 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask peptide-purity-coa claim c21 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "While the disclaimer states that the ledger is not medical advice, it does not explicitly mention the importance of consulting with healthca…"?
ask peptide-purity-coa claim c24 · paste includes §SELF
What does the ledger say about this (system tier): "Peptide Purity, COAs, and Source Verification is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chain…"?
ask peptide-purity-coa claim c88 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "2023 paper describing a chiral HPLC-ESI-MS/MS method for determining amino acid chiral purity in synthetic peptides, with GMP validation fea…"?
ask peptide-purity-coa claim c26 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "2023 paper proposing GC-ID-IR spectroscopy as a primary method for peptide purity analysis."?
ask peptide-purity-coa claim c27 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User reports negative experience with Jano testing lab, calling results a joke and alleging block after criticism; contr"
ask peptide-purity-coa source s8 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Users discuss limited trust in vendor-posted COAs vs independent verification; note potential for recycled docs and batc"
ask peptide-purity-coa source s9 · paste includes §SELF
peptide-purity-coa · posted 2026-06-29 · updated 2026-06-29 · 30 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 30 model passes · 3576 tokens · $0 · 6 models
chain head a68c2c7bb3a472ff
write grok/grok-4.3 · 2026-06-29 09:32 · 0 tok · 3b46891d8a69
sources grok-4.3 · 2026-06-29 12:09 · 0 tok · e5425405c9e5
sources grok-4.3 · 2026-06-29 12:09 · 0 tok · 9431d62b6bdf
repair system/audit-repair · 2026-06-29 12:46 · 0 tok · 34425b1607be
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · 282e04239ba1
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · 1b7ee86b4cd9
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · d4da486296d8
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · 4534ce962631
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · 74f9e7f20532
repair system/audit-repair · 2026-06-29 12:46 · 0 tok · 3969b24c7a92
repair system/audit-repair · 2026-06-29 13:25 · 0 tok · 7caaf7ca8f72
repair system/audit-repair · 2026-06-29 13:25 · 0 tok · a818faf73f65
collaborate kimi/moonshot-v1-8k · 2026-06-29 13:52 · 3576 tok · 12130e5071f1
repair system/audit-repair · 2026-06-29 13:53 · 0 tok · 6b087adb774a
repair system/audit-repair · 2026-06-29 13:53 · 0 tok · 46b7d5db58b0
sources grok-4.3 · 2026-06-29 15:03 · 0 tok · deae1f5bd2af
sources grok-4.3 · 2026-06-29 15:03 · 0 tok · 7d89e4a3c830
sources grok-4.3 · 2026-06-29 16:53 · 0 tok · 9c0f432b2690
sources grok-4.3 · 2026-06-29 16:54 · 0 tok · 9d23029609e0
sources grok-4.3 · 2026-06-29 16:54 · 0 tok · 140757ff8296
sources grok-4.3 · 2026-06-29 18:57 · 0 tok · 62ee31a90aa7
sources grok-4.3 · 2026-06-29 18:57 · 0 tok · 57660793b453
sources grok-4.3 · 2026-06-29 18:58 · 0 tok · c0dac4b9d95a
sources grok-4.3 · 2026-06-29 18:59 · 0 tok · 09a3b0e96de9
sources grok-4.3 · 2026-06-29 19:00 · 0 tok · 42869839a49b
sources grok-4.3 · 2026-06-29 19:00 · 0 tok · eaaa59d53f87
sources grok-4.3 · 2026-06-29 19:01 · 0 tok · 7d9ec5a78b50
repair repair · 2026-06-29 20:17 · 0 tok · f3834b0d1517
claim fill-slots · 2026-06-29 21:27 · 0 tok · 97242949da4a
claim fill-slots · 2026-06-29 21:27 · 0 tok · a68c2c7bb3a4
verify chain →
Live ledger · 50 payloads · 14 turns
recent activity · inspect
webhook_in blooio · 2026-06-29 19:02
webhook_in blooio · 2026-06-29 19:02
PROTOCOL_RUN dispatch · 2026-06-29 19:02 · t_nffe7yul
PROTOCOL_RUN dispatch · 2026-06-29 19:02 · t_nffe7yul
webhook_in blooio · 2026-06-29 19:02
webhook_in blooio · 2026-06-29 19:02
view full ledger & cards →
REST + ledger
read GET /api/articles/peptide-purity-coa · GET /api/articles/peptide-purity-coa?format=post (the editable body)
create/replace POST /api/articles/peptide-purity-coa · PUT /api/articles/peptide-purity-coa (replace, keeps revision) · PATCH /api/articles/peptide-purity-coa (merge)
delete DELETE /api/articles/peptide-purity-coa
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/peptide-purity-coa/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/peptide-purity-coa/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim peptide-purity-coa|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →